COVID-19: clinical diagnostics

3:30 PM • 596 • Understanding intensive care unit (ICU) clinicians' beliefs about broad-spectrum antibiotic usage and molecular diagnostic utility during the COVID-19 pandemic > A. Alyssa Megan PANDOLFO (London) 3:40 PM • 992 • SARS-CoV-2 RT- qPCR Cq values of are of limited value for patient risk stratification and assay performance evaluation > J. Jim HUGGETT (Guildford) 3:50 PM • 3128 • Incidence and characteristics of ventilator-associated pneumonia patients with COVID-19: a multi-centre study > A. Ana MOTOS GALERA (Barcelona) 4:00 PM • 4173 • Co-infections in patients with severe COVID-19 in a national intensive care tertiary referral centre > G. Grace CHAN (Dublin) 4:10 PM • 4213 • SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality in a severely affected area of Madrid, Spain > R. Ramon PÉREZ TANOIRA (Madrid) 4:20 PM • 4510 • Application of respiratory metagenomics for COVID-19 patients on the intensive care unit for rapid identification of bacterial and fungal secondary infections and rapid detection of nosocomial transmission > L. Luke Blagdon SNELL (London) 4:30 PM • 4551 • Profile of viral co-infections in COVID-19 patients in a tertiary care Indian hospital > M. Monalisa SAHU (Hyderabad) 4:40 PM • INT21 • Q&A/Discussion